Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis

Clinical Chemistry and Laboratory Medicine

Volumn 39, Issue 5, 2001, Pages 380-384

  Noji, Y ^a   Kajinami, K ^a   Kawashiri, M A ^a   Todo, Y ^a   Horita, T ^a   Nohara, A ^a   Higashikata, T ^a   Inazu, A ^a   Koizumi, J ^a   Takegoshi, T ^a   Mabuchi, H ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; HDL cholesterol; LDL cholesterol; Lipoproteins; Matrix metalloproteinases: Plasma

Indexed keywords

GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTERY WALL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPIDS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PROTEASE INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRIGLYCERIDES;

EID: 17844365837     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2001.060     Document Type: Article

References (29)

1. Matrix metalloproteinases and cardiovascular disease
2. Matrix metalloproteinases and coronary artery disease: A novel therapeutic target
3. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus
4. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
5. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies
6. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies
7. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases; an application for rheumatoid arthritis serum and plasma
8. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies
9. Serum apolipoproteins in heterozygous familial hypercholesterolemia
10. Comparison of two homogenous assays with a precipitation method and an ultracentrifugation method for the measurement of HDL-cholesterol
11. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
12. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
13. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy
14. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
15. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma
16. Increased serum 72 kDa metalloproteinase in serous ovarian tumors: Comparison with CA 125
17. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma
18. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response
19. Changes in serum concentrations of matrix metalloproteinase, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis
20. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction
21. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthrites: A potentially useful laboratory marker
22. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis
23. Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis
24. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
25. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
26. Plasma MMP-9 levels are elevated in patients with abdominal aortic aneurysms
27. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes
28. Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 tissue inhibitor of metalloproteinase 2 in blood
29. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma; A potential mechanism of lesion stabilization